down arrow

Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
670.00
-16.85 (-2.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 40.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
988.00
894.07
860.15
615.63
281.14
278.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
988.00
894.07
860.15
615.63
281.14
278.14
Raw Material Cost
608.40
634.98
578.98
375.79
173.24
173.64
Purchase of Finished goods
84.89
63.15
60.25
101.54
0.00
0.00
(Increase) / Decrease In Stocks
-11.69
-65.86
-26.58
-18.26
-1.44
-3.72
Employee Cost
61.15
52.05
47.66
25.54
19.53
17.54
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
114.43
88.43
85.56
49.99
36.01
40.05
Total Expenditure (Excl Depreciation)
857.18
772.76
745.87
534.60
227.34
227.52
Operating Profit (PBDIT) excl Other Income
130.82
121.31
114.28
81.03
53.80
50.62
Other Income
1.67
3.55
1.56
7.03
5.55
1.62
Operating Profit (PBDIT)
132.49
124.86
115.84
88.06
59.35
52.24
Interest
7.37
11.35
13.30
2.56
1.83
1.67
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
125.12
113.51
102.54
85.50
57.52
50.57
Depreciation
30.53
29.23
30.96
16.51
9.38
7.84
Profit Before Tax
94.60
84.30
71.59
68.99
48.15
42.73
Tax
24.87
22.10
19.72
18.28
12.33
10.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.73
62.20
51.87
50.71
35.81
31.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.73
62.20
51.87
50.71
35.81
31.90
Share in Profit of Associates
0.50
-0.03
0.73
0.06
0.41
0.00
Minority Interest
0.00
0.00
0.00
-0.02
-0.03
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
70.23
62.17
52.60
50.75
36.19
31.90
Equity Capital
11.06
11.05
11.03
11.01
10.39
4.40
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
353.18
Earnings per share (EPS)
12.7
11.25
9.54
9.22
6.97
6.59
Diluted Earnings per share
12.69
11.24
9.49
9.29
7.02
6.59
Operating Profit Margin (Excl OI)
13.24%
13.57%
13.29%
13.16%
19.14%
18.2%
Gross Profit Margin
12.66%
12.7%
11.92%
13.89%
20.46%
18.18%
PAT Margin
7.11%
6.95%
6.12%
8.25%
12.88%
11.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 10.51% vs 3.94% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 12.96% vs 18.19% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 7.84% vs 6.15% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is -35.07% vs -14.66% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of Rossari Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
988.00
4,198.84
-3,210.84
-76.47%
Other Operating Income
0.00
0.00
0.00
Total Operating income
988.00
4,198.84
-3,210.84
-76.47%
Raw Material Cost
608.40
2,869.15
-2,260.75
-78.80%
Purchase of Finished goods
84.89
99.52
-14.63
-14.70%
(Increase) / Decrease In Stocks
-11.69
-86.20
74.51
86.44%
Employee Cost
61.15
192.41
-131.26
-68.22%
Power Cost
0.00
240.15
-240.15
-100.00%
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
114.43
277.10
-162.67
-58.70%
Total Expenditure (Excl Depreciation)
857.18
3,592.13
-2,734.95
-76.14%
Operating Profit (PBDIT) excl Other Income
130.82
606.71
-475.89
-78.44%
Other Income
1.67
40.08
-38.41
-95.83%
Operating Profit (PBDIT)
132.49
646.79
-514.30
-79.52%
Interest
7.37
12.05
-4.68
-38.84%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
125.12
634.74
-509.62
-80.29%
Depreciation
30.53
95.91
-65.38
-68.17%
Profit Before Tax
94.60
538.83
-444.23
-82.44%
Tax
24.87
142.10
-117.23
-82.50%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
69.73
396.73
-327.00
-82.42%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
69.73
396.73
-327.00
-82.42%
Share in Profit of Associates
0.50
0.00
0.50
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
70.23
396.73
-326.50
-82.30%
Equity Capital
11.06
27.28
-16.22
-59.46%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.70
29.09
-16.39
-56.34%
Diluted Earnings per share
12.69
29.09
-16.40
-56.38%
Operating Profit Margin (Excl OI)
13.24%
14.45%
0.00
-1.21%
Gross Profit Margin
12.66%
15.12%
0.00
-2.46%
PAT Margin
7.11%
9.45%
0.00
-2.34%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 988.00 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 10.51% vs 3.94% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 70.23 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 12.96% vs 18.19% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 130.82 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 7.84% vs 6.15% in Sep 2023

Half Yearly - Interest
Interest 7.37 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -35.07% vs -14.66% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.24%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023